Some patients remain at lower doses longer if results are already strong
#LpaAwarenessDay #KnowYourLpa #lipoproteina To view or add a comment, sign in Im pleased to share our latest publication in Annual Reports in Medicinal Chemistry: How to reduce side effects of GLP-1 based obesity medications, co-authored with Prof
LLY stock has fallen by 6.53% compared to the previous week, the month change is a 5.90% fall, over the last year Eli Lilly and Company has showed a 50.15% increase
if pancreatitis is suspected, do not take any further doses and seek urgent medical assessment immediately [15] [16] Pain in the upper right abdomen, or yellowing of the skin or whites of the eyes (jaundice) these may indicate gallbladder disease, a risk associated with rapid weight loss and GLP-1 receptor agonist use [16] [17] Fever accompanying diarrhoea, which may suggest an infective cause requiring separate investigation Significant unintentional weight loss beyond what is expected from the treatment For people with type 2 diabetes: persistent diarrhoea can reduce carbohydrate absorption and increase the risk of hypoglycaemia, particularly if insulin or sulphonylureas are co-prescribed
Some patients stay on GLP-1 medications long term while others taper off after reaching their weight goal
Eredetileg mregtelents cljbl vettem, kt ht alatt 3kilt fogytam, majd mg 2 kilt gy hogy az tkezsemen nem vltoztattam